Full Text
EE167 Cost-Effectiveness Evaluations of CAR-T Cell Therapies By Health Technology Assessment Agencies

Abstract

Authors

G Dorneles CLP de Araujo NB Schneider M Falavigna

Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×